[1]Lok AS, Heathcote EJ, Hoofnagle JH.Managemenant of hepatitis B:2000-summary of a workshop[J].Gastroenterology, 2001, 120∶1828-1853.
|
[2]Tang ZY.Hepatocellular carcinoma-cause, treatment and metasta-sis[J].World J Gastroenterol, 2001, 7∶445-454.
|
[3]郭尧君.蛋白质电泳技术[M].北京:科学出版社, 1999∶54-142.
|
[4]Molloy MP.Two-dimensional electrophoresis of membrane proteinsusing immobilized pHgradients[J].Anal Biochem, 2000, 280∶1-10.
|
[5]Rappsilber J, Mann M.What does it mean to identify a protein inproteomics[J]?Trends Biochen Sci, 2002, 27∶74-78.
|
[6]Petricoin EF, Ardekani AM, Hitt BA, et al.Use of proteomic pat-terns in serum to identify ovarian cancer[J].Lancet, 2002, 359∶572-577.
|
[7]Sandrin L, Fourquet B, Hasquenoph JM, et al.Transient elastogra-phy:a new noninvasive method for assessment of hepaticfibrosis[J].Ultrasound Med Biol, 2003, 29∶1705-1713.
|
[1] | Xiaoting LI, Bobin HU, Hongyu LIU, Chao JIN, Cailian CAI, Keshan WANG, Yanchun WEI, Jianning JIANG, Minghua SU. Effectiveness of fibrosis-4 versus aspartate aminotransferase-to-platelet ratio index in evaluating liver fibrosis degree in patients with chronic HBV infection[J]. Journal of Clinical Hepatology, 2024, 40(12): 2424-2429. doi: 10.12449/JCH241212 |
[2] | Zhiyi WANG, Guangyue YANG, Wei ZHANG, Yaqiong PU, Xin ZHAO, Wenting MA, Xuling LIU, Liu WU, Le TAO, Cheng LIU. Role of podoplanin in hepatic stellate cell activation and liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(3): 533-538. doi: 10.12449/JCH240316 |
[3] | Long HUANG, Hongqian LIANG, Aoli REN, Minghua SU, Bobin HU, Qingmei LI, Tumei SU, Qianbing YIN, Yanfei FENG, Jianning JIANG. Diagnostic value of serum extra-spindle pole-like protein 1 in the progression of hepatitis B virus-related liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1785-1789. doi: 10.12449/JCH240911 |
[4] | Hui LIU, Fengmin LU, Jutao GUO. Mechanism of action, clinical research and development, and application prospect of hepatitis B virus core protein allosteric modulators[J]. Journal of Clinical Hepatology, 2022, 38(8): 1726-1732. doi: 10.3969/j.issn.1001-5256.2022.08.005 |
[5] | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association. 2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus[J]. Journal of Clinical Hepatology, 2020, 36(7): 1474-1481. doi: 10.3760/cma.j.cn112141-20200213-00101 |
[6] | Zhang LiJun, Jia XiaoFang, Wu DaGe, Liu XiaoQian, Huang Yan, Zhang JiaoLi, Cheng NengNeng. Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(10): 1053-1059. doi: 10.3969/j.issn.1001-5256.2014.10.020 |
[7] | Wang JianGang, Fei XinYing, Song Qing. Application of proteomics in study of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 958-960. doi: 10.3969/j.issn.1001-5256.2014.09.030 |
[8] | Zhang LiJun, Jia XiaoFang, Teng ZhenLin, Cheng NengNeng. Biomarkers of liver cancer related to hepatitis B virus selected by proteomics[J]. Journal of Clinical Hepatology, 2011, 27(5): 553-557. |
[10] | Xia Qi, Fu JieHai, Cai WeiMin, Liu RongHua. Diagnostic value of AST/PLT and GGT/PLT for hepatic fibrosis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 364-366. |
[11] | Xie Fang, Lin ZunHui, Jin HaiYing, Guo XiangHua, Huang YanXiang, Yin JiMing, Yan Yan, Hao Wa, Niu JingQin, Li Zhuo. The applied value of Dane granule antigen of hepatitis B viral in detecting chronic hepatitis B infection[J]. Journal of Clinical Hepatology, 2007, 23(6): 415-417. |
[12] | Jiang WeiPing, Lai LiYing, Li XinHua, Chen DongPing. Study on the linkage between variation of YMDD in hepatitis B virus and hepatic fibrosis serum markers[J]. Journal of Clinical Hepatology, 2004, 20(6): 345-346. |